BioMosaics

Welcome to BioMosaics

BioMosaics is a biomarker development company. We commercialize biomarker assays and reagents for the early detection of cancer, for use in clinical and research settings. In addition to our antibody products for clinical immunohistochemistry, we are developing novel oncology immunoassays for circulating tumor markers, as well as assays for detection of DNA damage and somatic mutation.